PRKAG1 Antibody (N-Term) Blocking Peptide Synthetic Peptide Catalog # Bp11853a

10320 Camino Santa Fe, Suite G San Diego, CA 92121 Tel: 858.875.1900 Fax: 858.622.0609

PRKAG1 Antibody (N-term) Blocking peptide Synthetic peptide Catalog # BP11853a

Specification

PRKAG1 Antibody (N-term) Blocking PRKAG1 Antibody (N-term) Blocking peptide - peptide - Background Product Information The protein encoded by this gene belongs to Primary Accession P54619 thephosphoinositide 3-kinase (PI3K) family. PI3-kinases play roles insignaling pathways involved in cell proliferation, PRKAG1 Antibody (N-term) Blocking peptide - Additional Information oncogenictransformation, cell survival, cell migration, and intracellularprotein trafficking. This protein contains a lipid kinase Gene ID 5571 catalyticdomain as well as a C-terminal C2 domain, a characteristic of classII PI3-kinases. Other Names C2 domains act as calcium-dependent 5'-AMP-activated protein kinase subunit phospholipidbinding motifs that mediate gamma-1, AMPK gamma1, AMPK subunit translocation of proteins to membranes,and gamma-1, AMPKg, PRKAG1 may also mediate protein-protein interactions. Format The PI3-kinaseactivity of this protein is not Peptides are lyophilized in a solid powder sensitive to nanomolar levels ofthe inhibitor format. Peptides can be reconstituted in wortmanin. This protein was shown to be able solution using the appropriate buffer as to beactivated by insulin and may be involved needed. in integrin-dependentsignaling.

Storage PRKAG1 Antibody (N-term) Blocking Maintain refrigerated at 2-8°C for up to 6 peptide - References months. For long term storage store at -20°C. Liu, C.Y., et al. Carcinogenesis 31(7):1259-1263(2010)Rose, J.E., et al. Mol. Precautions Med. 16 (7-8), 247-253 (2010) :Kostakis, G.C., This product is for research use only. Not et al. Oral Surg Oral Med Oral Pathol Oral for use in diagnostic or therapeutic Radiol Endod 109 (5), E53-E58 (2010) :Koutros, procedures. S., et al. Cancer Res. 70(6):2389-2396(2010)Ng, S.K., et al. Biochem. Biophys. Res. Commun. 387(2):310-315(2009) PRKAG1 Antibody (N-term) Blocking peptide - Protein Information

Name PRKAG1

Function AMP/ATP-binding subunit of AMP-activated protein kinase (AMPK), an energy sensor protein kinase that plays a key role in regulating cellular energy metabolism. In response to reduction of intracellular ATP levels, AMPK activates energy-producing pathways and inhibits energy-consuming processes: inhibits protein, carbohydrate and lipid biosynthesis, as well as cell growth

Page 1/2 10320 Camino Santa Fe, Suite G San Diego, CA 92121 Tel: 858.875.1900 Fax: 858.622.0609

and proliferation. AMPK acts via direct phosphorylation of metabolic enzymes, and by longer-term effects via phosphorylation of transcription regulators. Also acts as a regulator of cellular polarity by remodeling the actin cytoskeleton; probably by indirectly activating myosin. Gamma non-catalytic subunit mediates binding to AMP, ADP and ATP, leading to activate or inhibit AMPK: AMP-binding results in allosteric activation of alpha catalytic subunit (PRKAA1 or PRKAA2) both by inducing phosphorylation and preventing dephosphorylation of catalytic subunits. ADP also stimulates phosphorylation, without stimulating already phosphorylated catalytic subunit. ATP promotes dephosphorylation of catalytic subunit, rendering the AMPK enzyme inactive.

PRKAG1 Antibody (N-term) Blocking peptide - Protocols

Provided below are standard protocols that you may find useful for product applications.

• Blocking Peptides

Page 2/2